Prime Medicine, Inc. reports

Company 1 identity field
Location
Cambridge, MA
SEC filing record 1 source field
Fiscal year end
31 December
Prime Medicine, Inc. has filed 287 SEC EDGAR filings since 20 Dec 2021

SEC filing history

Showing 226-250 of 287 matching filings.

Per page
25
Current page
10
4

FORM 4

Filing date
26 Oct 2022
Reporting date
24 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Oct 2022
Reporting date
24 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Oct 2022
Reporting date
24 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Oct 2022
Reporting date
24 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93800

SC 13G filing

Filing date
26 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41536

8-K

Filing date
24 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A

Filing date
24 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-267579

424B4

Filing date
21 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-267579

FWP

Filing date
20 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
19 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-267579

EFFECT filing

Filing date
19 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Oct 2022
Reporting date
19 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .